As a Contract Research Organization, the company offers a complete and integrated range of services to pharmaceutical and veterinary companies, public or private research centers and associations, helping its clients to find practical solutions for their products development in a short time.

Farmacore has a diversified product portfolio consisting of Active Dendritic Cells-based Immunotherapy, DNA vaccines, subunit vaccines, vetorized vaccines and immunomodulators in clinical and pre-clinical development for a variety of infectious diseases and cancers.